magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Jason Gardner

magentatx.com/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Nordea Bank Abp: Managers' transactions - Änkilä

This Is How Drilling Tools' Rental Model Drives Cash Flow

Sarepta Plans FDA Filings Seeking Full Approval for Two DMD Therapies

The AI IPO I'm Most Excited About (And No, It's Not OpenAI, Anthropic or xAI)

Chubb Details Structure of the Gulf Maritime Insurance Facility with DFC

Nebius Is a High‑Risk Swing—But Could the Payoff Justify the Volatility?

Lithium Americas shares drop on fourth quarter earnings miss

Superstar Stock Seagate Surges on Institutional Inflows

One simple reason to 'avoid' buying the dip in SMCI stock today

Lands' End's Q4 Earnings Miss, U.S. Digital Segment Sales Up 5.3%

Cadence and NVIDIA Redefining Chip Design With Agentic AI: Here's How

Itron & Ausgrid Tackle Solar Surge With Intelligent Grid Management

Nordea Bank Abp: Managers' transactions - Persson

Banks Ready to Put Billions to Work After Regulatory Win

The Only S&P 500 ETF You Need in 2026 and It's Not the One You Think

Nordea Bank Abp: Managers' transactions - Smith

Arm's stock could rocket 50% as Wall Street wakes up to a ‘game-changing' trend, analyst says

Opinion | Time to Take Oil out of Newsom's Hands

Nordea Bank Abp: Managers' transactions - Gadeberg

DoorDash vs. Shopify: Which E-Commerce Stock Has an Edge Now?

About